Evaxion A (EVAX) Other Non-Current Assets (2019 - 2025)
Evaxion A (EVAX) posted Other Non-Current Assets of $185000.0 for Q4 2025, little changed on a QoQ basis from $185000.0 in Q2 2025, and up 14.2% year-over-year from $162000.0 in Q4 2024.
Evaxion A (EVAX) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Evaxion A's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $185000.0 for Q4 2025.
- Quarterly Other Non-Current Assets rose 14.2% year-over-year to $185000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $185000.0 (up 14.2% YoY) and the FY2025 annual result came in at $185000.0, up 14.2% from the prior year.
- Other Non-Current Assets was $185000.0 for Q4 2025 at Evaxion A, roughly flat from $185000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $200000.0 in Q2 2021 and bottomed at $148000.0 in Q2 2022.
- A 5-year average of $175076.9 and a median of $167000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets retreated 26.0% — and 2025, when it increased 14.2%.
- Evaxion A's Other Non-Current Assets stood at $191000.0 in 2021, then slipped by 18.32% to $156000.0 in 2022, then climbed by 7.05% to $167000.0 in 2023, then slipped by 2.99% to $162000.0 in 2024, then rose by 14.2% to $185000.0 in 2025.
- Business Quant data shows EVAX's Other Non-Current Assets at $185000.0 in Q4 2025, $185000.0 in Q2 2025, and $162000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 185,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Jun 30, 2023 | 165,000.00 |
| Dec 31, 2022 | 156,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 165,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Sep 30, 2021 | 194,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 193,000.00 |
| Dec 31, 2020 | 238,000.00 |
| Dec 31, 2019 | 25,000.00 |